TCL Archive NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also February 16, 1996
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004